Literature DB >> 18801330

A novel approach to enhance antibody sensitivity and specificity by peptide cross-linking.

Takeshi Namiki1, Julio C Valencia, Matthew D Hall, Vincent J Hearing.   

Abstract

Most current techniques employed to improve antigen-antibody signals in Western blotting and in immunohistochemistry rely on sample processing prior to staining (e.g., microwaving) or using a more robust reporter (e.g., a secondary antibody with biotin-streptavidin). We have developed and optimized a new approach intended to stabilize the complexes formed between antigens and their respective primary antibodies by cupric ions at high pH. This technique improves the affinity and lowers cross-reactivity with nonspecific bands of approximately 20% of antibodies tested (5/25). Here we report that this method can enhance antigen-antibody specificity and can improve the utility of some poorly reactive primary antibodies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18801330      PMCID: PMC2596928          DOI: 10.1016/j.ab.2008.08.024

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  16 in total

1.  Measurement of protein in 20 seconds using a microwave BCA assay.

Authors:  R E Akins; R S Tuan
Journal:  Biotechniques       Date:  1992-04       Impact factor: 1.993

2.  Mutations in the gene encoding B, a novel transporter protein, reduce melanin content in medaka.

Authors:  S Fukamachi; A Shimada; A Shima
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

Review 3.  Crystal structures of metal-peptide complexes.

Authors:  H C Freeman
Journal:  Adv Protein Chem       Date:  1967

4.  The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase.

Authors:  Kazutomo Toyofuku; Julio C Valencia; Tsuneto Kushimoto; Gertrude-E Costin; Victoria M Virador; Wilfred D Vieira; Victor J Ferrans; Vincent J Hearing
Journal:  Pigment Cell Res       Date:  2002-06

5.  A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth.

Authors:  D C Bennett; P J Cooper; I R Hart
Journal:  Int J Cancer       Date:  1987-03-15       Impact factor: 7.396

6.  Specific cleavage of immunoglobulin G by copper ions.

Authors:  M A Smith; M Easton; P Everett; G Lewis; M Payne; V Riveros-Moreno; G Allen
Journal:  Int J Pept Protein Res       Date:  1996-07

7.  Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes.

Authors:  A M Gown; A M Vogel; D Hoak; F Gough; M A McNutt
Journal:  Am J Pathol       Date:  1986-05       Impact factor: 4.307

8.  Tyrosinases from two different loci are expressed by normal and by transformed melanocytes.

Authors:  M Jiménez; K Tsukamoto; V J Hearing
Journal:  J Biol Chem       Date:  1991-01-15       Impact factor: 5.157

9.  Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4.

Authors:  Gertrude-E Costin; Julio C Valencia; Wilfred D Vieira; M Lynn Lamoreux; Vincent J Hearing
Journal:  J Cell Sci       Date:  2003-08-01       Impact factor: 5.285

10.  A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase.

Authors:  K Tsukamoto; I J Jackson; K Urabe; P M Montague; V J Hearing
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.